Drug intelligence / Profile preview

Folican Plus

Development stage
Unknown
Lead developer
Med Manor Organics
Modality
Small Molecules
Administration
Oral
01

Overview

Folican Plus is a combination nutritional supplement developed by Med Manor Organics, containing L-methylfolate, methylcobalamin, and pyridoxal 5-phosphate. It is primarily indicated for the prevention and treatment of nutritional deficiencies, particularly during preconception, pregnancy, and lactation, to support healthy fetal development, red blood cell formation, and neurological function. L-methylfolate is the biologically active form of folate (vitamin B9) that bypasses the MTHFR enzymatic conversion step to support DNA synthesis and homocysteine regulation. Methylcobalamin is the active coenzyme form of vitamin B12 that promotes nerve myelination and cognitive health. Pyridoxal 5-phosphate is the active form of vitamin B6, which acts as a cofactor in amino acid metabolism and neurotransmitter synthesis. Together, these active B-vitamins help maintain normal homocysteine levels, support brain and nerve health, and manage anemia.

Brand names
Folican PlusFolican+
Other names
l-methylfolate + methylcobalamin + pyridoxal 5-phosphate
02

Targets

DDC (Aromatic L-amino acid decarboxylase)CBS (Cystathionine beta-synthase)FOLR1 (FRα)MTR (Methionine synthase)

Beyond the preview

Go deeper on Folican Plus.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Folican Plus.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call